Minnesota Oncology Hematology PA — Minneapolis, Minnesota

Public research footprint of Minnesota Oncology Hematology PA, compiled from the ClinicalTrials.gov public registry.

524

Registered studies

223

Active

Recruiting now

245

Completed

Stopped or withdrawn

Most-studied conditions

Stage IIIB Lung Cancer AJCC v8 · Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 · Advanced Lung Non-Squamous Non-Small Cell Carcinoma · Stage IIIA Lung Cancer AJCC v8

Recently updated registry entries

NCT06203600 — Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal… (Recruiting)
NCT04269902 — Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or… (Recruiting)
NCT05976763 — Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Minnesota Oncology Hematology PA?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.